Global X S&P Biotech ETF (ASX:CURE)
Australia · Delayed Price · Currency is AUD 63.32
-2.63 (-3.99%)
At close: Jan 27, 2026
ASX:CURE Holdings Information
ASX:CURE is an equity ETF with a total of 10 individual holdings. The top holdings are Moderna stock at 2.07%, Revolution Medicines at 1.77%, Vaxcyte at 1.44%, GRAIL at 1.42%, and Amicus Therapeutics at 1.40%.
Total Holdings
10
Top 10 Percentage
14.95%
Asset Class
Equity
ETF Category
Health Care
Assets
42.26M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | 2.07% |
| 2 | RVMD | Revolution Medicines, Inc. | 1.77% |
| 3 | PCVX | Vaxcyte, Inc. | 1.44% |
| 4 | GRAL | GRAIL, Inc. | 1.42% |
| 5 | FOLD | Amicus Therapeutics, Inc. | 1.40% |
| 6 | KRYS | Krystal Biotech, Inc. | 1.40% |
| 7 | MIRM | Mirum Pharmaceuticals, Inc. | 1.40% |
| 8 | ALKS | Alkermes plc | 1.38% |
| 9 | PRAX | Praxis Precision Medicines, Inc. | 1.35% |
| 10 | HALO | Halozyme Therapeutics, Inc. | 1.32% |
As of Jan 23, 2026